TGTX logo

TG Therapeutics, Inc. (TGTX) Selling, general & administrative expenses

annual SGA:

$154.30M+$31.59M(+25.75%)
December 31, 2024

Summary

  • As of today (July 16, 2025), TGTX annual SGA is $154.30 million, with the most recent change of +$31.59 million (+25.75%) on December 31, 2024.
  • During the last 3 years, TGTX annual SGA has risen by +$26.21 million (+20.46%).
  • TGTX annual SGA is now at all-time high.

Performance

TGTX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

quarterly SGA:

$50.33M+$11.37M(+29.18%)
March 1, 2025

Summary

  • As of today (July 16, 2025), TGTX quarterly SGA is $50.33 million, with the most recent change of +$11.37 million (+29.18%) on March 1, 2025.
  • Over the past year, TGTX quarterly SGA has increased by +$15.75 million (+45.55%).
  • TGTX quarterly SGA is now at all-time high.

Performance

TGTX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

TTM SGA:

-$6.16B+$934.00K(+0.02%)
March 1, 2025

Summary

  • As of today (July 16, 2025), TGTX TTM SGA is -$6.16 billion, with the most recent change of +$934.00 thousand (+0.02%) on March 1, 2025.
  • Over the past year, TGTX TTM SGA has dropped by -$6.29 billion (-4868.89%).
  • TGTX TTM SGA is now -96185.28% below its all-time high of -$6.40 million.

Performance

TGTX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

TGTX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.8%+45.5%-4868.9%
3 y3 years+20.5%+144.2%-5153.6%
5 y5 years+926.8%+252.9%-10000.0%

TGTX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+61.6%at high+298.3%-14.1%+1.1%
5 y5-yearat high+926.8%at high+298.3%-111.0%+1.1%
alltimeall timeat high>+9999.0%at high+5679.9%<-9999.0%+1.1%

TGTX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$50.33M(+29.2%)
$170.05M(+10.2%)
Dec 2024
$154.30M(+25.7%)
$38.96M(-7.2%)
$154.30M(+5.3%)
Sep 2024
-
$41.97M(+8.2%)
$146.49M(+6.7%)
Jun 2024
-
$38.79M(+12.2%)
$137.29M(+6.2%)
Mar 2024
-
$34.58M(+11.0%)
$129.22M(+5.3%)
Dec 2023
$122.71M(+28.5%)
$31.15M(-4.9%)
$122.70M(-12.1%)
Sep 2023
-
$32.77M(+6.7%)
$139.53M(+15.3%)
Jun 2023
-
$30.71M(+9.4%)
$121.02M(+17.6%)
Mar 2023
-
$28.07M(-41.5%)
$102.94M(+7.8%)
Dec 2022
$95.48M(-25.5%)
$47.98M(+236.6%)
$95.48M(+19.5%)
Sep 2022
-
$14.25M(+12.8%)
$79.91M(-20.5%)
Jun 2022
-
$12.64M(-38.7%)
$100.56M(-17.5%)
Mar 2022
-
$20.61M(-36.4%)
$121.94M(-4.8%)
Dec 2021
$128.09M(+18.8%)
$32.41M(-7.1%)
$128.09M(-8.2%)
Sep 2021
-
$34.90M(+2.6%)
$139.54M(-0.3%)
Jun 2021
-
$34.02M(+27.1%)
$139.93M(+16.3%)
Mar 2021
-
$26.76M(-39.0%)
$120.35M(+11.6%)
Dec 2020
$107.85M(+617.7%)
$43.86M(+24.3%)
$107.85M(+51.8%)
Sep 2020
-
$35.30M(+144.5%)
$71.05M(+83.8%)
Jun 2020
-
$14.43M(+1.2%)
$38.66M(+43.5%)
Mar 2020
-
$14.26M(+102.1%)
$26.95M(+79.3%)
Dec 2019
$15.03M(-0.9%)
$7.06M(+142.1%)
$15.03M(+52.0%)
Sep 2019
-
$2.91M(+7.3%)
$9.88M(+24.5%)
Jun 2019
-
$2.72M(+16.0%)
$7.94M(-27.2%)
Mar 2019
-
$2.34M(+22.5%)
$10.90M(-28.1%)
Dec 2018
$15.16M(-7.2%)
$1.91M(+97.5%)
$15.16M(-17.3%)
Sep 2018
-
$968.00K(-83.0%)
$18.32M(-16.1%)
Jun 2018
-
$5.68M(-13.9%)
$21.83M(+21.9%)
Mar 2018
-
$6.60M(+29.9%)
$17.91M(+9.6%)
Dec 2017
$16.33M(+65.1%)
$5.08M(+13.5%)
$16.33M(+25.3%)
Sep 2017
-
$4.47M(+154.6%)
$13.04M(+11.2%)
Jun 2017
-
$1.76M(-65.0%)
$11.73M(-6.2%)
Mar 2017
-
$5.02M(+181.7%)
$12.50M(+26.4%)
Dec 2016
$9.89M(-36.7%)
$1.78M(-43.7%)
$9.89M(-6.1%)
Sep 2016
-
$3.17M(+25.2%)
$10.53M(+9.1%)
Jun 2016
-
$2.53M(+4.8%)
$9.65M(-25.8%)
Mar 2016
-
$2.41M(-0.5%)
$13.01M(-16.7%)
Dec 2015
$15.63M(-1.0%)
$2.42M(+5.9%)
$15.63M(-7.1%)
Sep 2015
-
$2.29M(-61.1%)
$16.82M(-8.2%)
Jun 2015
-
$5.89M(+17.2%)
$18.32M(+4.2%)
Mar 2015
-
$5.02M(+38.7%)
$17.58M(+11.3%)
Dec 2014
$15.79M(+137.1%)
$3.62M(-4.3%)
$15.79M(+15.9%)
Sep 2014
-
$3.79M(-26.4%)
$13.63M(+21.5%)
Jun 2014
-
$5.15M(+59.1%)
$11.22M(+45.5%)
Mar 2014
-
$3.23M(+121.4%)
$7.71M(+15.8%)
Dec 2013
$6.66M(+39.2%)
$1.46M(+6.2%)
$6.66M(-1.0%)
Sep 2013
-
$1.38M(-16.1%)
$6.72M(+3.4%)
Jun 2013
-
$1.64M(-24.9%)
$6.50M(+2.9%)
Mar 2013
-
$2.18M(+43.1%)
$6.32M(+32.2%)
Dec 2012
$4.78M(+762.0%)
$1.53M(+32.2%)
$4.78M(+25.9%)
Sep 2012
-
$1.15M(-20.9%)
$3.80M(+42.9%)
Jun 2012
-
$1.46M(+126.5%)
$2.66M(+121.7%)
Mar 2012
-
$644.00K(+19.1%)
$1.20M(-31.6%)
Dec 2011
$554.70K(-63.5%)
$540.50K(+3706.3%)
$1.75M(+19.3%)
Sep 2011
-
$14.20K(>+9900.0%)
$1.47M(-15.3%)
Jun 2011
-
$0.00(-100.0%)
$1.73M(-21.5%)
Mar 2011
-
$1.20M(+367.7%)
$2.21M(+45.2%)
Dec 2010
$1.52M
$256.30K(-8.1%)
$1.52M(-6.3%)
DateAnnualQuarterlyTTM
Sep 2010
-
$278.90K(-41.2%)
$1.62M(-6.4%)
Jun 2010
-
$474.10K(-7.3%)
$1.73M(+0.2%)
Mar 2010
-
$511.70K(+42.9%)
$1.73M(-0.0%)
Dec 2009
$1.73M(-33.7%)
$358.10K(-8.2%)
$1.73M(+25.2%)
Sep 2009
-
$390.10K(-17.1%)
$1.38M(-26.3%)
Jun 2009
-
$470.60K(-8.2%)
$1.88M(-18.7%)
Mar 2009
-
$512.40K(+5237.5%)
$2.31M(-11.6%)
Dec 2008
$2.61M(-27.7%)
$9600.00(-98.9%)
$2.61M(-21.9%)
Sep 2008
-
$884.70K(-1.9%)
$3.34M(-0.4%)
Jun 2008
-
$901.50K(+10.7%)
$3.36M(-4.3%)
Mar 2008
-
$814.10K(+9.6%)
$3.51M(-2.8%)
Dec 2007
$3.61M(-5.7%)
$743.10K(-17.3%)
$3.61M(-13.5%)
Sep 2007
-
$898.10K(-14.7%)
$4.17M(-0.6%)
Jun 2007
-
$1.05M(+15.1%)
$4.20M(+6.8%)
Mar 2007
-
$914.70K(-30.0%)
$3.93M(+2.7%)
Dec 2006
$3.83M(+67.1%)
$1.31M(+41.4%)
$3.83M(+16.9%)
Sep 2006
-
$923.80K(+17.5%)
$3.27M(+15.2%)
Jun 2006
-
$786.40K(-3.0%)
$2.84M(+8.9%)
Mar 2006
-
$810.90K(+7.6%)
$2.61M(+13.9%)
Dec 2005
$2.29M(+15.1%)
$753.80K(+53.6%)
$2.29M(+10.0%)
Sep 2005
-
$490.90K(-11.3%)
$2.08M(-3.3%)
Jun 2005
-
$553.20K(+12.2%)
$2.16M(+4.1%)
Mar 2005
-
$493.20K(-9.7%)
$2.07M(+4.0%)
Dec 2004
$1.99M(+11.4%)
$546.10K(-3.0%)
$1.99M(+0.8%)
Sep 2004
-
$562.80K(+20.3%)
$1.97M(+8.2%)
Jun 2004
-
$467.80K(+13.2%)
$1.82M(+0.2%)
Mar 2004
-
$413.20K(-22.1%)
$1.82M(+1.9%)
Dec 2003
$1.79M(+462.7%)
$530.60K(+28.6%)
$1.79M(+405.4%)
Sep 2003
-
$412.70K(-11.0%)
$353.40K(-12.4%)
Jun 2003
-
$463.80K(+22.4%)
$403.60K(-4018.4%)
Mar 2003
-
$378.90K(-142.0%)
-$10.30K(-126.7%)
Dec 2002
$317.40K(-88.9%)
-$902.00K(-294.9%)
$38.60K(-97.2%)
Sep 2002
-
$462.90K(+827.7%)
$1.39M(-4.8%)
Jun 2002
-
$49.90K(-88.3%)
$1.46M(-43.7%)
Mar 2002
-
$427.80K(-4.0%)
$2.58M(-9.3%)
Dec 2001
$2.85M(-12.5%)
$445.80K(-16.3%)
$2.85M(+1.1%)
Sep 2001
-
$532.30K(-54.8%)
$2.82M(-0.8%)
Jun 2001
-
$1.18M(+69.8%)
$2.84M(-41.2%)
Mar 2001
-
$693.90K(+67.1%)
$4.84M(-14.1%)
Dec 2000
$3.26M(+71.4%)
$415.20K(-25.1%)
$5.63M(-6.4%)
Sep 2000
-
$554.20K(-82.5%)
$6.01M(+2.6%)
Jun 2000
-
$3.17M(+113.4%)
$5.86M(+96.2%)
Mar 2000
-
$1.49M(+85.8%)
$2.99M(+57.2%)
Dec 1999
$1.90M(-29.6%)
$800.00K(+100.0%)
$1.90M(+35.7%)
Sep 1999
-
$400.00K(+33.3%)
$1.40M(-22.2%)
Jun 1999
-
$300.00K(-25.0%)
$1.80M(-28.0%)
Mar 1999
-
$400.00K(+33.3%)
$2.50M(-7.4%)
Dec 1998
$2.70M(-3.6%)
$300.00K(-62.5%)
$2.70M(-15.6%)
Sep 1998
-
$800.00K(-20.0%)
$3.20M(+6.7%)
Jun 1998
-
$1.00M(+66.7%)
$3.00M(+11.1%)
Mar 1998
-
$600.00K(-25.0%)
$2.70M(-3.6%)
Dec 1997
$2.80M(+3.7%)
$800.00K(+33.3%)
$2.80M(+3.7%)
Sep 1997
-
$600.00K(-14.3%)
$2.70M(-10.0%)
Jun 1997
-
$700.00K(0.0%)
$3.00M(+7.1%)
Mar 1997
-
$700.00K(0.0%)
$2.80M(+33.3%)
Dec 1996
$2.70M
$700.00K(-22.2%)
$2.10M(+50.0%)
Sep 1996
-
$900.00K(+80.0%)
$1.40M(+180.0%)
Jun 1996
-
$500.00K
$500.00K

FAQ

  • What is TG Therapeutics, Inc. annual SGA?
  • What is the all time high annual SGA for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual SGA year-on-year change?
  • What is TG Therapeutics, Inc. quarterly SGA?
  • What is the all time high quarterly SGA for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly SGA year-on-year change?
  • What is TG Therapeutics, Inc. TTM SGA?
  • What is the all time high TTM SGA for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. TTM SGA year-on-year change?

What is TG Therapeutics, Inc. annual SGA?

The current annual SGA of TGTX is $154.30M

What is the all time high annual SGA for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual SGA is $154.30M

What is TG Therapeutics, Inc. annual SGA year-on-year change?

Over the past year, TGTX annual SGA has changed by +$31.59M (+25.75%)

What is TG Therapeutics, Inc. quarterly SGA?

The current quarterly SGA of TGTX is $50.33M

What is the all time high quarterly SGA for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly SGA is $50.33M

What is TG Therapeutics, Inc. quarterly SGA year-on-year change?

Over the past year, TGTX quarterly SGA has changed by +$15.75M (+45.55%)

What is TG Therapeutics, Inc. TTM SGA?

The current TTM SGA of TGTX is -$6.16B

What is the all time high TTM SGA for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high TTM SGA is -$6.40M

What is TG Therapeutics, Inc. TTM SGA year-on-year change?

Over the past year, TGTX TTM SGA has changed by -$6.29B (-4868.89%)
On this page